BCB Bancorp IncBCB Bancorp disclosed an expected Q3 net loss of US$126.2m-US$136.1m with US$112m-US$120m in provisions and a US$98m common stock offering at US$7.75, prompting fair-value and price-target cuts.

BCB Bancorp's updated fair value estimate has been lowered to US$9.45 from US$11.75, bringing it closer to recent Street price targets of around US$8 to US$9 per share. The reset follows the company's disclosure of an expected Q3 net loss of US$126.2m to US$136.1m and US$112m to US$120m in provisions, alongside a US$98m common stock offering at US$7.75 per share and a planned US$75m follow-on stock offering. Brean Capital downgraded BCB Bancorp to Neutral from Buy with a US$9 price target, while Keefe Bruyette cut its target to US$8.35 from US$11 and maintained a Market Perform rating. Brean Capital noted a swift pace of credit resolution with planned loan sales over the next two to six weeks, and said recent credit and capital actions could position BCB Bancorp for a potential sale in early to mid 2027. The updated model also shifted its revenue growth assumption to 33.39% from 25.59%, its net profit margin assumption to 30.14% from 45.41%, its future P/E multiple to 5.31x from 3.78x, and its discount rate to 7.86% from 8.42%.
BCB Bancorp IncBCB Bancorp disclosed an expected Q3 net loss of US$126.2m-US$136.1m with US$112m-US$120m in provisions and a US$98m common stock offering at US$7.75, prompting fair-value and price-target cuts.
Yulon Finance CorpBrean Capital downgraded BCB Bancorp to Neutral from Buy with a US$9 price target, though it noted credit actions could position BCB for a potential sale in early to mid 2027.